Zambon Switzerland Ltd
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Switzerland
- Registered address
- Via Industria 13, CADEMPINO, Ticino 6814, Switzerland (CHE)
- Operations here
- manufacture
- FDA identifiers
- FEI 3002807274 · DUNS 481761344
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-12-12
- NAIDrug Quality Assurance2019-12-13
- NAIDrug Quality Assurance2018-02-13
- VAIDrug Quality Assurance2016-03-30
- VAIDrug Quality Assurance2013-12-19
- NAIDrug Quality Assurance2010-07-07
Drugs this plant is listed as making
2 distinct drugs across 4 products name this site in their FDA label.
- Imipenem and Cilastatin SodiumFresenius Kabi USA, LLC
- MeropenemFresenius Kabi USA, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.